Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Plymouth Meeting, Pennsylvania
- Most recent report
- 10-Q, filed Aug 4, 2026
- Incorporated
- Delaware
- Filings on record
- 448 filings
- On EDGAR
- CIK 1802665
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 25
News 8 of 77
Prospectuses and Registrations 8 of 13
- S-8 Registration statement for an employee plan Feb 25, 2025
- S-3ASR Automatic shelf registration Feb 25, 2025
- S-8 Registration statement for an employee plan Feb 22, 2024
- S-8 Registration statement for an employee plan May 2, 2023
- S-8 Registration statement for an employee plan Feb 28, 2022
- 424B5 Prospectus supplement for an offering Nov 9, 2021
- S-3ASR Automatic shelf registration Nov 9, 2021
- S-8 Registration statement for an employee plan Aug 21, 2020
Proxies 8 of 12
- DEFA14A Extra proxy material Apr 3, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 3, 2026
- DEFA14A Extra proxy material Apr 4, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 4, 2025
- DEFA14A Extra proxy material Apr 11, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 11, 2024
- DEFA14A Extra proxy material Apr 14, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 14, 2023
Ownership 8 of 290
- 144 Notice of a proposed sale of restricted stock Aug 7, 2026
- SCHEDULE 13G Large holder reported a passive stake Jul 31, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Jul 28, 2026
- 3 Insider reported their initial holding Jul 22, 2026
- 144 Notice of a proposed sale of restricted stock Jul 2, 2026
- 144 Notice of a proposed sale of restricted stock Jun 30, 2026
- 144 Notice of a proposed sale of restricted stock Jun 26, 2026
- 144 Notice of a proposed sale of restricted stock Jun 24, 2026
Other 8 of 31
- ARS Annual report sent to shareholders Apr 3, 2026
- UPLOAD Comment letter from SEC staff Apr 15, 2025
- CORRESP Reply to SEC staff Apr 9, 2025
- ARS Annual report sent to shareholders Apr 4, 2025
- UPLOAD Comment letter from SEC staff Mar 28, 2025
- 424B7 Oct 31, 2024
- 424B7 Oct 29, 2024
- ARS Annual report sent to shareholders Apr 11, 2024
Everything here comes from Harmony Biosciences Holdings, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.